Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CDIO | US
0
0%
Healthcare
Biotechnology
30/06/2024
24/04/2026
1.82
1.82
1.89
1.80
Cardio Diagnostics Holdings Inc. an artificial intelligence-powered precision cardiovascular medicine company develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events including heart attacks; and PrecisionCHD an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago Illinois.
View LessValue Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
49.5%1 month
87.3%3 months
251.7%6 months
197.4%-
-
2.10
0.28
0.22
-22.48
151.27
-
-8.22M
55.69M
55.69M
-
-16.30K
-
356.20
-293.27
1.55
13.77
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.37
Range1M
0.57
Range3M
6.94
Rel. volume
0.29
Price X volume
52.64K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Nuo Therapeutics Inc | AURX | Biotechnology | 1.3 | 60.58M | n/a | 0.00% | |
| Acrivon Therapeutics Inc. | ACRV | Biotechnology | 1.91 | 59.16M | 1.06% | n/a | 1.95% |
| QNCX | QNCX | Biotechnology | 1.36 | 58.86M | 0.00% | n/a | 30.62% |
| OKYO Pharma Limited | OKYO | Biotechnology | 1.61 | 54.48M | 1.26% | n/a | -107.88% |
| Rani Therapeutics Holdings Inc. Class A Common Stock | RANI | Biotechnology | 0.9389 | 54.33M | 2.56% | n/a | 1243.32% |
| LYRA THERAPEUTICS INC | LYRA | Biotechnology | 0.8 | 52.37M | 10.34% | n/a | 118.63% |
| 22nd Century Group Inc | XXII | Biotechnology | 1.66 | 52.18M | -2.92% | n/a | -1072.15% |
| Cognition Therapeutics Inc. Common Stock | CGTX | Biotechnology | 1.28 | 51.37M | 1.59% | n/a | 2.71% |
| Gain Therapeutics Inc. Common Stock | GANX | Biotechnology | 1.97 | 50.30M | 4.23% | n/a | 6.85% |
| PEPG | PEPG | Biotechnology | 1.54 | 50.19M | -3.14% | n/a | 12.52% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 21.77 | 33.16M | -2.81% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.57 | 11.01M | -3.37% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5165 | 7.55M | -0.67% | 0.03 | 16.03% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.38 | 3.52M | 0.23% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.199 | 1.89M | 1.38% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.27 | 699.77K | -6.62% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0055 | 507.18K | -37.50% | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -22.48 | 0.53 | Cheaper |
| Ent. to Revenue | 151.27 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.10 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 251.75 | 72.80 | Riskier |
| Debt to Equity | 0.28 | -1.23 | Expensive |
| Debt to Assets | 0.22 | 0.25 | Par |
| Market Cap | 55.69M | 3.66B | Emerging |